| Not Yet Recruiting | my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults NCT07516353 | Dana-Farber Cancer Institute | N/A |
| Recruiting | A Multicenter Study of CAR-T Cells in Primary Ph+All NCT07252336 | Zhejiang University | Phase 2 |
| Recruiting | A Long Term Follow-up Study of TScan TCR-T Products NCT06976736 | TScan Therapeutics, Inc. | — |
| Recruiting | UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy NCT06047886 | University of Alabama at Birmingham | Phase 1 |
| Completed | Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults NCT06244147 | SF Research Institute, Inc. | — |
| Recruiting | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801 | Children's Hospital Medical Center, Cincinnati | — |
| Active Not Recruiting | Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childho NCT05550948 | St. Jude Children's Research Hospital | N/A |
| Recruiting | Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies NCT05476770 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 1 |
| Unknown | commd7 Gene Expression in ALL NCT05592470 | Assiut University | — |
| Withdrawn | Patient Satisfaction in the Orthopedic Surgery Clinic NCT04343027 | NYU Langone Health | N/A |
| Recruiting | Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL NCT05940961 | Sheng-Li Xue, MD | Phase 2 |
| Unknown | Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy NCT05414162 | University Hospital, Bonn | — |
| Active Not Recruiting | Venetoclax Plus Inotuzumab for B-ALL NCT05016947 | Dana-Farber Cancer Institute | Phase 1 |
| Unknown | ACL Reconstruction With/Without ALL Reconstruction NCT05461625 | Centre of Postgraduate Medical Education | N/A |
| Recruiting | Optical Genome Mapping in Hematological Malignancies NCT05009537 | University Hospital, Brest | — |
| Recruiting | Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL NCT04601584 | AO GENERIUM | Phase 1 / Phase 2 |
| Completed | Haplo Peripheral Blood Sct In GVHD Prevention NCT04473911 | Zachariah Michael DeFilipp | Phase 1 |
| Unknown | Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Iso NCT05123456 | Ramsay Générale de Santé | N/A |
| Recruiting | Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia NCT03571321 | University of Chicago | Phase 1 |
| Recruiting | A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Tr NCT03739502 | University of Rochester | Phase 2 |
| Completed | Haploidentical Donor vs mMUD in Hematological Malignancies NCT03275636 | DKMS gemeinnützige GmbH | Phase 2 / Phase 3 |
| Terminated | Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders NCT03198234 | Roncarolo, Maria Grazia, MD | Phase 1 |
| Completed | Family History in a Singaporean Healthy Population NCT03114553 | Duke University | — |
| Active Not Recruiting | Project Baseline Health Study NCT03154346 | Baseline Study LLC | — |
| Recruiting | Amish/Mennonite Research Contact Registry NCT02990572 | University of Pittsburgh | — |
| Unknown | Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia NCT02776605 | PETHEMA Foundation | Phase 2 |
| Terminated | Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Ac NCT02795520 | OncoTherapy Science, Inc. | Phase 1 / Phase 2 |
| Unknown | Collaborative Network to Take Responsibility for Oral Anticancer Therapy NCT02861209 | KU Leuven | N/A |
| Completed | Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing NCT02315612 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Photochemotherapy and Graft-versus-leukemia in Acute-leukemia NCT02631993 | Karolinska University Hospital | — |
| Completed | Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL NCT02133599 | Ann & Robert H Lurie Children's Hospital of Chicago | N/A |
| Completed | Massage Therapy Versus Music Therapy Pilot Study NCT02227680 | Boston Medical Center | N/A |
| Completed | Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood NCT02528435 | University of Aarhus | — |
| Completed | Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma NCT01593696 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives NCT01532635 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients NCT01319864 | Seattle Children's Hospital | Phase 1 |
| Terminated | Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia NCT01230788 | Emory University | N/A |
| Completed | Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies NCT01204164 | Tragara Pharmaceuticals, Inc. | Phase 1 |
| Completed | Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT NCT01012492 | Boston Children's Hospital | Phase 2 |
| Completed | Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients NCT00863148 | Nantes University Hospital | Phase 2 |
| Completed | A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic NCT00964873 | Synta Pharmaceuticals Corp. | Phase 1 |
| Completed | Umbilical Cord Blood Transplant for Hematological Malignancies NCT00891592 | University of Pennsylvania | Phase 1 |
| Unknown | Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) NCT00815568 | Samsung Medical Center | Phase 2 |
| Terminated | Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Gr NCT00814983 | Duke University | Phase 1 / Phase 2 |
| Completed | Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD NCT00539695 | Baylor College of Medicine | Phase 2 |
| Terminated | Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies NCT00776373 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Completed | Testing the Re-Engineered Hospital Discharge NCT00252057 | Boston University | N/A |
| Completed | CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation NCT00333190 | Dana-Farber Cancer Institute | N/A |
| Completed | Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of He NCT00533923 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic NCT00013533 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders NCT00636909 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders NCT00511537 | University of California, San Francisco | — |